Nagpur, Maharashtra
GST No. 27CMXPD8281K1Z6
Call 07949083170
Send Enquiry
| Strength | 6 mg/ ml |
| Packaging Type | Box |
| Brand | Victoza |
| Manufacturer | NOVO NORDISK |
| Usage / Application | Hospital |
| Shelf Life | 36 Months |
| Storage Conditions | 2-8 degree centigrade |
| Country of Origin | Made in India |
View Complete details
| Strength | 10 mg |
| Form | Tablets |
| Composition | Empagliflozin (10mg) |
| Packaging Size | 10 Tablets in 1 stripe |
| Packaging Type | Box |
| Brand | Boehringer Ingelheim |
| Prescription/Non prescription | Non prescription |
| Shelf life | 36 Months |
View Complete details
| Packaging Size | 15 Tablets in 1 stripe |
| Packaging Type | Box |
| Form | Tablets |
| Composition | Metformin (850mg) + Vildagliptin (50mg) |
| Brand | Galvus Met 50mg/850mg |
| Prescription/Non prescription | Non prescription |
| Shelf life | 36 Months |
| Manufacturer | Novartis India Ltd |
| Strength | 50 mg/850 mg |
View Complete details
| Packaging Size | 3 ml |
| Strength | 100 IU/ml |
| Composition | 100U/ml |
| Packaging Type | Piece |
| Brand | Actrapid |
| Manufacturer | Novo Nordisk India Pvt Ltd |
| Salt | Human insulin (100IU) |
View Complete details
| Strength | 10 mg |
| Form | Tablets |
| Composition | Dapagliflozin (10mg) |
| Packaging Size | 14 Tablets in 1 Stripe |
| Packaging Type | Box |
| Brand | Forxiga 10mg |
| Shelf life | 36 Months |
View Complete details
| Strength | 5 mg |
| Form | Tablets |
| Composition | Dapagliflozin (10mg) + Linagliptin (5mg) |
| Packaging Size | 10 Tablets in 1 Stripe |
| Packaging Type | Box |
| Brand | Linaworth DP |
| Prescription/Non prescription | Prescription |
| Shelf life | 36 Months |
| Manufacturer | Morepen Laboratories Ltd |
View Complete details
| Strength | 500 mg |
| Form | Tablets |
| Pack Size | 1*10 Tablet |
| Pack Type | Strip |
| Brand | Myformin |
| Manufacturer | Morepen Laboratories Ltd |
| Shelf Life | 36 months |
| Usage | To Treat Type 2 Diabetes |
| Prescription / Non Prescription | Non Prescription |
View Complete details
| Strength | 5 mg |
| Form | Tablets |
| Composition | Linagliptin/Metformin Hydrochloride |
| Packaging Type | Bottle |
| Brand | Trajenta Duo |
| Shelf life | 24 Months |
| Usage | As per prescribed |
| Manufacturer | Boehringer Ingelheim |
View Complete details
| Strength | 5 mg |
| Form | Tablets |
| Composition | Linagliptin |
| Packaging Type | Strip |
| Brand | Trajenta |
| Usage | Trajenta 5mg Tablet is a medicine used to treat type 2 diabetes mellitus. |
| Manufacturer | Boehringer Ingelheim |
View Complete details
| strength | 3 mg |
| Form | Tablets |
| Packaging size | 10*10 Tablets |
| Packaging Type | Strip |
| Brand | Rybelsus |
| Manufacturer | Novo Nordisk |
| Shelf Life | 24 Months |
| Usuage | to treat type 2 diabetes |
View Complete details
| Strength | 25 mg |
| Form | Tablets |
| Composition | Empagliflozin (25mg) |
| Packaging Size | 10 Tablets in 1 Stripe |
| Packaging Type | Box |
| Brand | Boehringer Ingelheim |
| Prescription/Non prescription | Non prescription |
| Shelf life | 36 Months |
View Complete details
| strength | 7 mg |
| Form | Tablets |
| Packaging size | 10*10 Tablets |
| Packaging Type | Strip |
| Brand | Rybelsus |
| Manufacturer | Novo Nordisk |
| Shelf Life | 24 Months |
| Usuage | to treat type 2 diabetes |
View Complete details
| strength | 14 mg |
| Form | Tablets |
| Packaging size | 10*10 Tablets |
| Packaging Type | Strip |
| Brand | Rybelsus |
| Manufacturer | Novo Nordisk |
| Shelf Life | 24 Months |
| Usuage | to treat type 2 diabetes |
View Complete details
| Strength | 10 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Pre-filled pen |
| Brand | Tizaro |
| Manufacturer | Ziska Pharma |
| Prescription | No |
TIRZEPATIDE (tir ZEP a tide) treats type 2 diabetes. It works by increasing insulin levels in your body, which decreases your blood sugar (glucose). Changes to diet and exercise are often combined with this medication.
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
View Complete details
| Strength | 12.5 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Pre-filled pen |
| Brand | Tizaro |
| Manufacturer | Ziska Pharma |
| Prescription | No |
TIRZEPATIDE (tir ZEP a tide) treats type 2 diabetes. It works by increasing insulin levels in your body, which decreases your blood sugar (glucose). Changes to diet and exercise are often combined with this medication.
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
View Complete details
| Strength | 15 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Pre-filled pen |
| Brand | Tizaro |
| Manufacturer | Ziska Pharma |
| Prescription | No |
TIRZEPATIDE (tir ZEP a tide) treats type 2 diabetes. It works by increasing insulin levels in your body, which decreases your blood sugar (glucose). Changes to diet and exercise are often combined with this medication.
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
View Complete details
| Strength | 2.5 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Pre-filled pen |
| Brand | Tizaro |
| Manufacturer | Ziska Pharma |
| Composition | Tirzepatide (2.5mg) |
View Complete details
| Strength | 5 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Pre-filled pen |
| Brand | Tizaro |
| Manufacturer | Ziska Pharma |
| Prescription | No |
| Composition | Tirzepatide(5mg) |
TIRZEPATIDE (tir ZEP a tide) treats type 2 diabetes. It works by increasing insulin levels in your body, which decreases your blood sugar (glucose). Changes to diet and exercise are often combined with this medication.
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
View Complete details
| Strength | 7.5 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Pre-filled pen |
| Brand | Tizaro |
| Manufacturer | Ziska Pharma |
| Prescription | No |
| Composition | Tirzepatide (7.5mg) |
View Complete details
| Dose/Strength | 6 mg/ml |
| Packaging Size | 3 ml |
| Packaging Type | Box |
| Brand | Erly |
| Manufacturer | Eris Lifesciences Ltd |
| Composition | Liraglutide (6mg/ml) |
View Complete details
| Dose/Strength | 6 mg/ml |
| Packaging Size | 3 ml |
| Packaging Type | Box |
| Brand | Lirafit |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Composition | Liraglutide (6mg/ml) |
View Complete details
| Strength | 5 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Injection |
| Brand | Mounjaro |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Prescription | No |
| Composition | Tirzepatide (5mg) |
Mounjaro 5mg Solution for Injection is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the medication properly in the refrigerator.
Common side effects of Mounjaro 5mg Solution for Injection include nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are typically mild and improve over time. If they become severe or persistent, consult a doctor. They can help by adjusting the dose or suggesting ways to prevent them. Drinking plenty of water and staying hydrated may also help reduce discomfort from gastrointestinal symptoms.
Mounjaro 5mg Solution for Injection should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnant individuals or those planning to become pregnant should avoid this medicine as it may cause harmful effects on the developing baby. Before taking this medicine, inform your doctor about all the other medicines you are taking to avoid interaction.
View Complete details
| Strength | 2.5 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Injection |
| Brand | Mounjaro |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Composition | Tirzepatide (2.5mg) |
Mounjaro 2.5mg Solution for Injection is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the medication properly in the refrigerator.
Common side effects of Mounjaro 2.5mg Solution for Injection include nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are typically mild and improve over time. If they become severe or persistent, consult a doctor. They can help by adjusting the dose or suggesting ways to prevent them. Drinking plenty of water and staying hydrated may also help reduce discomfort from gastrointestinal symptoms.
Mounjaro 2.5mg Solution for Injection should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnant individuals or those planning to become pregnant should avoid this medicine as it may cause harmful effects on the developing baby. Before taking this medicine, inform your doctor about all the other medicines you are taking to avoid interaction.
View Complete details
| Packaging Type | Box |
| Manufacturer | Incepta pharma |
| Usage / Application | Personal |
| Shelf Life | 24 months |
| Form | Injection |
View Complete details
| Strength | 40 IU/ml |
| Form | Injection |
| Packaging Type | Box |
| Packaging Size | Box |
| Manufacturer | Incepta pharma |
| Usage / Application | Personal |
| Shelf Life | 36 months |
| Prescription/Non prescription | Non prescription |
| Prescription/Non-Prescription | Non-Prescription |
| Usage | As per prescribed |
View Complete details
| Packaging Size | 0.5 ml |
| Packaging Type | Box |
| Brand | Trucility |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Shelf Life | 56 Days |
View Complete details
| Strength | 10 mg |
| Form | Tablets |
| Packaging Size | 10 Tablets in 1 Stripe |
| Packaging Type | Box |
| Composition | Empagliflozin (10mg) |
| Brand name | Gibtulio |
| Manufactured By | Lupin Ltd |
Gibtulio 10mg Tablet can be taken with or without food at any time of day, but you should try to take it at the same time every day. Your doctor will decide the dose. Do not stop taking it without asking your doctor. If you do, your blood sugar levels may increase, putting you at risk of serious complications like kidney damage and blindness. This medicine is only part of a treatment program that should include a healthy diet, regular exercise, and weight reduction, as your doctor advises.
The most common side effects of this medicine are urinary tract infections and female genital mycotic infections (vaginal yeast infections). It may cause the body to lose too much water. Hence, drink plenty of fluids to stay hydrated and to overcome the medicine's side effects. Some people may develop fungal infections in the genital area. Maintaining good hygiene can help prevent this.
Before taking this medicine, inform your doctor if you have any kidney or liver problems, a urinary tract infection, or are taking water pills (diuretics). Pregnant or breastfeeding women should also consult their doctor before taking it. Avoid excessive alcohol intake while taking it, as this may increase the risk of developing some side effects. Monitor your blood sugar levels regularly while taking this medicine.
View Complete details
| Strength | 25 mg |
| Packaging Type | Box |
| Composition | Empagliflozin (25mg) |
| Form | Tablets |
| Packaging Size | 10 Tablets in 1 Stripe |
| Brand Name | Gibtulio |
| Manufactured By | Lupin Ltd |
Gibtulio 25mg Tablet can be taken with or without food at any time of day, but you should try to take it at the same time every day. Your doctor will decide the dose. Do not stop taking it without asking your doctor. If you do, your blood sugar levels may increase, putting you at risk of serious complications like kidney damage and blindness. This medicine is only part of a treatment program that should include a healthy diet, regular exercise, and weight reduction, as your doctor advises.
The most common side effects of this medicine are urinary tract infections and female genital mycotic infections (vaginal yeast infections). It may cause the body to lose too much water. Hence, drink plenty of fluids to stay hydrated and to overcome the medicine's side effects. Some people may develop fungal infections in the genital area. Maintaining good hygiene can help prevent this.
Before taking this medicine, inform your doctor if you have any kidney or liver problems, a urinary tract infection, or are taking water pills (diuretics). Pregnant or breastfeeding women should also consult their doctor before taking it. Avoid excessive alcohol intake while taking it, as this may increase the risk of developing some side effects. Monitor your blood sugar levels regularly while taking this medicine.
View Complete details
| strength | 1mg |
| Packaging Type | Box |
| Brand | W-E-G-O-V-Y |
| Manufacturer | Novo Nordisk India Pvt Ltd |
| Shelf Life | 36 Months |
| Usuage | to treat type 2 diabetes |
| Composition | Semaglutide (1mg) |
View Complete details
| Strength | 7.5 mg |
| Packaging Size | 3ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Composition | Tirzepatide (7.5mg) |
Mounjaro 7.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 7.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.
Common side effects of Mounjaro 7.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.
Mounjaro 7.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 7.5mg KwikPen.
Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
View Complete details
| Strength | 2.5 mg |
| Packaging Size | 3ml |
| Packaging Type | Pre-filled pen |
| Brand | Moujaro |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Composition | Tirzepatide (2.5mg) |
Mounjaro 2.5mg Kwikpen for Injection is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 2.5mg Kwikpen for Injection. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.
Common side effects of Mounjaro 2.5mg Kwikpen for Injection are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.
Mounjaro 2.5mg Kwikpen for Injection is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 2.5mg Solution for Injection.
Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
View Complete details
| Strength | 5 mg |
| Packaging Size | 3ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Composition | Tirzepatide (5mg) |
Mounjaro 5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.
Common side effects of Mounjaro 5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.
Mounjaro 5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 5mg KwikPen.
Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
View Complete details
| Strength | 10 mg |
| Packaging Size | 3ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Composition | Tirzepatide (10mg) |
Mounjaro 10mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 10mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.
Common side effects of Mounjaro 10mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.
Mounjaro 10mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 10mg KwikPen.
Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
View Complete details
| Strength | 12.5 mg |
| Packaging Size | 3ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Composition | Tirzepatide (12.5mg) |
Mounjaro 12.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 12.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.
Common side effects of Mounjaro 12.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.
Mounjaro 12.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 12.5mg KwikPen.
Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
View Complete details
| Strength | 15 mg |
| Packaging Size | 3ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro |
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| Composition | Tirzepatide (15mg) |
Mounjaro 15mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 15mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.
Common side effects of Mounjaro 15mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.
Mounjaro 15mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 15mg KwikPen.
Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
View Complete details
| Form | Injection |
| Packaging Type | Box |
| Manufacturer | Incepta pharma |
| Usage / Application | Personal |
| Shelf Life | 24months |
| Prescription/Non prescription | Non prescription |
| Usage | As Per prescribed |
View Complete details
| Form | Injection |
| Packaging Type | Box |
| Manufacturer | Incepta pharma |
| Usage / Application | Personal |
| Shelf Life | 24 Months |
| Prescription/Non prescription | Non prescription |
| Usage | As per prescribed |
View Complete details
| Dose/Strength | 100 mg |
| Form | Tablets |
| Packaging Size | 10*10 Tablets |
| Composition | Sitagliptin, Dapagliflozin and Metformin Hydrochloride (ER) Tablets |
| Packaging Type | Stripe |
| Manufacturer | VERITAS PHARMA |
| Shelf Life | 36 Months |
View Complete details
| Dose/Strength | 20 mg |
| Form | Tablets |
| Packaging Type | Box |
| Packaging Size | 1*10 Tablets |
| Brand | Teneright |
| Manufactured By | Morepen Laboratories Ltd |
| Composition | Teneligliptin (20mg) |
| Shell Life | 36 Months |
View Complete details
| Dose/Strength | 50 mg |
| Form | Tablets |
| Packaging Size | 1*10 Tablets |
| Composition | Sitagliptin (50mg) + Metformin (1000mg) |
| Packaging Type | Box |
| Manufacturer | Healing Pharma India Pvt Ltd |
| Prescription/Non prescription | Non prescription |
| Shelf Life | 36 Months |
Sitasmart-M 50/1000 Tablet can be prescribed alone or together with other diabetes medications. All diabetes medicines work best when used along with a healthy diet and regular exercise. The dose you are given will depend on your condition, blood sugar levels, and what other medicines you are taking. Taking it with meals helps to reduce the chances of developing an upset stomach.
You should take it regularly, at the same time each day, to get the most benefit and you should not stop unless your doctor recommends it. It is controlling your blood sugar levels and helping to prevent serious complications in the future. It is important to stay on the diet and exercise program recommended by your doctor while taking this medicine. Your lifestyle plays a big part in controlling diabetes.
The most common side effects of taking this medicine include diarrhea, nausea, vomiting, upset stomach, headache, and sore throat. Low blood sugar level (hypoglycemia) is a possible side effect if you are also taking other diabetes medicines like insulin or sulfonylurea, so you need to know how to recognize and deal with it.
This medicine is not suitable for everyone. Before taking it, you should let your doctor know if you have ever had kidney, liver or heart disease, problems with your pancreas, or if you drink a lot of alcohol. Pregnant or breastfeeding women should also consult their doctor before taking this medicine. Some other medicines can affect this one so tell your doctor about all the medicines you are taking to make sure you are safe. You should try to avoid drinking alcohol as it lowers blood glucose. Your doctor will check your kidney function and blood sugar levels before and during treatment.
View Complete details